CABALETTA BIO INC. - COMMON STOCK
1.8700
22-نوفمبر-24 15:44:58
15 متأخرة بدقائق
الأسهم
0.0000
0.00%
نطاق اليوم
1.8100 - 2.0100
ISIN
N/A
المصدر
NASDAQ
-
Cabaletta Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
05 يناير 2023 07:00:01 بحسب Nasdaq GlobeNewswire
-
Cabaletta Bio Announces $35 Million Offering
08 ديسمبر 2022 06:00:00 بحسب Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the 5th Annual Evercore ISI HealthCONx Conference
22 نوفمبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
Cabaletta Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
10 نوفمبر 2022 06:00:02 بحسب Nasdaq GlobeNewswire
-
11 أكتوبر 2022 06:00:00 بحسب Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the 29th Annual Congress of the European Society of Gene & Cell Therapy
06 أكتوبر 2022 07:00:02 بحسب Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the Chardan 6th Annual Genetic Medicines Conference
26 سبتمبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
Cabaletta Bio Presents New Interim Data from the DesCAARTes™ Phase 1 Trial at the 31st EADV Congress
10 سبتمبر 2022 06:00:00 بحسب Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
06 سبتمبر 2022 07:00:04 بحسب Nasdaq GlobeNewswire
-
Cabaletta Bio to Present Data at the 31st EADV Congress and Provides Update on DesCAARTes™ Trial
29 أغسطس 2022 12:58:30 بحسب Nasdaq GlobeNewswire
-
Cabaletta Bio Reports Second Quarter 2022 Financial Results and Provides Business Update
11 أغسطس 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
18 مايو 2022 06:00:00 بحسب Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the H.C. Wainwright Global Investment Conference
17 مايو 2022 07:00:04 بحسب Nasdaq GlobeNewswire
-
Cabaletta Bio Reports First Quarter 2022 Financial Results and Provides Business Update
12 مايو 2022 06:00:02 بحسب Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the 21st Annual Needham Virtual Healthcare Conference
06 أبريل 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
17 مارس 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
U.S. Food and Drug Administration Grants Cabaletta Bio Fast Track Designation for MuSK-CAART
01 مارس 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in the Cowen Virtual 42nd Annual Health Care Conference
28 فبراير 2022 07:00:02 بحسب Nasdaq GlobeNewswire
-
11 يناير 2022 07:00:02 بحسب Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference
10 يناير 2022 07:00:04 بحسب Nasdaq GlobeNewswire